Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brek Eaton

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|February 18, 2010
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessationF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry|December 14, 2011
Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activityLi-Fang Yu, Werner Tückmantel, J Brek Eaton, et al.
Molecular Pharmacology|August 24, 2004
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptorsM Imad Damaj, F Ivy Carroll, J Brek Eaton, et al.
Journal of Medicinal Chemistry|June 6, 2013
Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part IIHan-Kun Zhang, Li-Fang Yu, J Brek Eaton, et al.
European Journal of Medicinal Chemistry|September 19, 2016
Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonistsHan-Kun Zhang, J Brek Eaton, Allison Fedolak, et al.
Journal of Medicinal Chemistry|February 16, 2011
Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotineF Ivy Carroll, Ana Z Muresan, Bruce E Blough, et al.
Molecular Pharmacology|December 3, 2003
Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cellsJ Brek Eaton, Jian-Hong Peng, Katherine M Schroeder, et al.
Chemmedchem|July 2, 2009
Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depressionAlan P Kozikowski, J Brek Eaton, Krishna Mohan Bajjuri, et al.
Journal of Medicinal Chemistry|June 1, 2010
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessationRonald J Lukas, Ana Z Muresan, M Imad Damaj, et al.
ACS Chemical Biology|July 31, 2018
α1-FANGs: Protein Ligands Selective for the α-Bungarotoxin Site of the α1-Nicotinic Acetylcholine ReceptorAaron L Nichols, Kaori Noridomi, Christopher R Hughes, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|February 18, 2010
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessationF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry|December 14, 2011
Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activityLi-Fang Yu, Werner Tückmantel, J Brek Eaton, et al.
Molecular Pharmacology|August 24, 2004
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptorsM Imad Damaj, F Ivy Carroll, J Brek Eaton, et al.
Journal of Medicinal Chemistry|June 6, 2013
Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part IIHan-Kun Zhang, Li-Fang Yu, J Brek Eaton, et al.
European Journal of Medicinal Chemistry|September 19, 2016
Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonistsHan-Kun Zhang, J Brek Eaton, Allison Fedolak, et al.
Journal of Medicinal Chemistry|February 16, 2011
Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotineF Ivy Carroll, Ana Z Muresan, Bruce E Blough, et al.
Molecular Pharmacology|December 3, 2003
Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cellsJ Brek Eaton, Jian-Hong Peng, Katherine M Schroeder, et al.
Chemmedchem|July 2, 2009
Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depressionAlan P Kozikowski, J Brek Eaton, Krishna Mohan Bajjuri, et al.
Journal of Medicinal Chemistry|June 1, 2010
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessationRonald J Lukas, Ana Z Muresan, M Imad Damaj, et al.
ACS Chemical Biology|July 31, 2018
α1-FANGs: Protein Ligands Selective for the α-Bungarotoxin Site of the α1-Nicotinic Acetylcholine ReceptorAaron L Nichols, Kaori Noridomi, Christopher R Hughes, et al.
Pageof 3